Centre advises Ayush drugs for Covid prevention, management
New Delhi, January 12
The government on Wednesday recommended Ayush drugs for prevention and management of Covid-19 saying clinical and preclinical trials had established the efficacy of the medicines.
Issuing revised guidelines for Ayush interventions in Covid-19, the ministry of Ayush said current understanding indicated that a good immune system was important for prevention of the disease.
“Based on clinical and preclinical studies Ayush medicine has been recommended for prophylaxis and management. In the current scenario we recommend three medicines for prophylaxis,” Ayush Ministry officials said today.
These three medicines are Ayuraksha kit which consists of Chyawanprash 6 gm a day; Ayush kwath 75 ml (3gm powder boiled in 150 ml water and reduced to 75 ml) once a day; Samshamani vati 500 mg twice a day; Anu Taila once a day one to two drops nasal application in each nostril once a day.
The second prophylaxis intervention in the Ayush guideline is Guduchi Ghan Vati 500 mg twice a day; third is Ashwagandha tablet 500 mg twice a day.
The ministry said during the first wave, 19,000 Delhi police personnel were given Ashwagandha tablets and a peer reviewed research was published to show they were either not infected or did not progress to severe disease.
For management, the ministry suggested AYUSH 64, a poly herbal formulation developed by the Central Council of Research in Ayurvedic Sciences along with CSIR. “Seven clinical studies were done and were found effective for management through AYUSH 64 of which 2 tablets of 500 mg twice a day are recommended for management of asymptomatic cases and 2 tablets of 500 mg thrice a day for mild to moderate Covid,” said the ministry.
